Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T17:58:00.808Z.
Calculation as of: 2026-10-06T17:58:00.808Z.
Quote observation: 2026-10-06T17:54:34.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4fd5d7af3ee6af72921bc315e5ba82b5757c441ca2a41ed9c1ba6c6f3afb8810
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Regencell Bioscience Holdings Limited
Market Cap
$3.79B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.55B
Free Cash Flow Yield
1.10%
TTM Avg
0.68%
3Y Avg
0.59%
5Y Avg
0.59%
Market Cap
$3.95B
Free Cash Flow Yield
3.87%
TTM Avg
2.45%
3Y Avg
3.11%
5Y Avg
3.04%
Market Cap
$4.00B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.48B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.48B
Free Cash Flow Yield
N/A
TTM Avg
6.75%
3Y Avg
6.75%
5Y Avg
6.75%
Market Cap
$3.48B
Free Cash Flow Yield
N/A
TTM Avg
9.07%
3Y Avg
9.10%
5Y Avg
9.10%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Regencell Bioscience Holdings Limited (RGC) | $3.79B | N/A | N/A | N/A | N/A |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.55B | 1.10% | 0.68% | 0.59% | 0.59% |
| ICU Medical, Inc. (ICUI)vs › | $3.95B | 3.87% | 2.45% | 3.11% | 3.04% |
| Veracyte, Inc. (VCYT)vs › | $3.53B | 4.69% | 3.79% | 2.70% | 2.46% |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.00B | N/A | N/A | N/A | N/A |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.48B | N/A | N/A | N/A | N/A |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.48B | N/A | 6.75% | 6.75% | 6.75% |
| Celcuity Inc. (CELC)vs › | $3.47B | N/A | N/A | N/A | N/A |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | N/A | 9.07% | 9.10% | 9.10% |
| AbCellera Biologics Inc. (ABCL)vs › | $4.02B | N/A | 6.32% | 4.83% | 4.83% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
